Influence on the long-term outcome of renal allografts by fosfomycin.
Hoyer
J
J
Department of Surgery, Medical University, Luebeck, Germany.
Winterhoff
R
R
Fricke
L
L
Sack
K
K
D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005578:Fosfomycin / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013256:Steroids; D005578:Fosfomycin; D016572:Cyclosporine